Fundies.
English

PAR PHARMACEUTICAL COMPANIES, INC.

EDGAR
Quarterly report (10-Q) · filed 2015-08-06

98 filing records in this dataset, filed from 1994-12-29 to 2015-08-06. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

326 million USD

2015 Q2 · USD

Exact inputs and evidence

Operating margin

14.08%

2015 Q2 · %

Exact inputs and evidence
  • Operating Income: 45858000 USD Source
  • Revenue: 325745000 USD Source

Operating cash flow

432 thousand USD

2015 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: 100639000 USD Source
  • Operating Cash Flow: 100207000 USD Source
Cash and cash equivalents
155 million USD Source
Exact value

154852000 USD

Long-term debt including current maturities
1.55 billion USD Source
Exact value

1545340000 USD

Shares outstanding
Not available

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2015-08-06.

Financial data available through: 2013-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2011-12-31
  • Operating income: 3 of 11 periods available· newest 2011-12-31
  • Net income: 2 of 11 periods available· newest 2013-12-31
  • Operating cash flow: 3 of 11 periods available· newest 2011-12-31
  • Capital expenditure: 1 of 11 periods available· newest 2003-12-31
  • Total assets: 4 of 11 periods available· newest 2013-12-31
  • liabilities: No compatible figures in this window
  • Current assets: 4 of 11 periods available· newest 2013-12-31
  • Current liabilities: 4 of 11 periods available· newest 2013-12-31
  • Cash and cash equivalents: 4 of 11 periods available· newest 2013-12-31
  • Long-term debt including current maturities: 2 of 11 periods available· newest 2013-12-31
  • shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

No unambiguous prior-year comparison is available for the latest reporting period.

Comparable inputs unavailable for: Revenue, Net income, Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2011 2011-01-01 – 2011-12-31

  • Revenue Unit12 887.5 million 100% of revenue
  • Operating costs Derived Unit12 938.09 million 106% of revenue
  • Operating income −Unit12 50.59 million −5.7% of revenue
  • Tax, interest and other Derived Unavailable An input is unavailable.
  • Net income Unavailable An input is unavailable.

Cash

  • Operating cash flow Unit12 64.98 million 7.3% of revenue
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2009 Not shown: operating income or net income is not reported.
  • 2010 Not shown: operating income or net income is not reported.
  • 2011 Not shown: operating income or net income is not reported.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2009 2009-01-01 – 2009-12-311176427000 1044957000 Derived 131470000 UnavailableUnavailableUnavailable
Source
2010 2010-01-01 – 2010-12-31980631000 847710000 Derived 132921000 UnavailableUnavailableUnavailable
Source
2011 2011-01-01 – 2011-12-31887495000 938088000 Derived -50593000 UnavailableUnavailableUnavailable
Source

Amounts are exact, in Unit12.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit12 887.5M 2011
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.3B952.9M635.3M317.6M0.0200920102011
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit12)Source evidence
2009Revenue1176427000
2010Revenue980631000
2011Revenue887495000

Revenue growth

Change in revenue from the same financial period one year earlier.

-9.5% 2011
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.3%-3.5%-8.3%-13.1%-18.0%200920102011
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2009Year over yearNo prior comparable period
2010Year over year-16.6%
2011Year over year-9.5%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -5.7% 2011
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.15.1%9.5%3.9%-1.7%-7.2%200920102011
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2009Operating margin11.2%
2010Operating margin13.6%
2011Operating margin-5.7%
2009-12-31Net marginNot reported
2010-12-31Net marginNot reported
2011-12-31Net marginNot reported
2009Free cash flow marginNot reported
2010Free cash flow marginNot reported
2011Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

Unit12 65M 2011
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.177.5M133.1M88.7M44.4M0.0200920102011
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit12)Source evidence
2009Operating cash flow53348000
2010Operating cash flow164309000
2011Operating cash flow64978000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit12)Source evidence
2009Free cash flowUnavailable
2010Free cash flowUnavailable
2011Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2009-12-31Liabilities / assetsNot reportedNo source recorded
2010-12-31Liabilities / assetsNot reportedNo source recorded
2011-12-31Liabilities / assetsNot reportedNo source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2009-12-31Current assets / current liabilitiesNot reportedNo source recorded
2010-12-31Current assets / current liabilitiesNot reportedNo source recorded
2011-12-31Current assets / current liabilitiesNot reportedNo source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2009 2009-01-01 – 2009-12-31
Unavailable Not reported for this period.
Unit12 53.35 million
Exact value

Exact value: 53348000 Unit12

2009-01-01 – 2009-12-31: 53348000 Unit12 Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2010 2010-01-01 – 2010-12-31
Unavailable Not reported for this period.
Unit12 164.31 million
Exact value

Exact value: 164309000 Unit12

2010-01-01 – 2010-12-31: 164309000 Unit12 Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2011 2011-01-01 – 2011-12-31
Unavailable Not reported for this period.
Unit12 64.98 million
Exact value

Exact value: 64978000 Unit12

2011-01-01 – 2011-12-31: 64978000 Unit12 Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

98 filings · 4,332 latest values · 4,332 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0000878088, 878088, edgar:878088

Also known as PAR PHARMACEUTICAL COMPANIES, INC., PHARMACEUTICAL RESOURCES INC